5 research outputs found

    Total synthesis of Melicopteline C-E

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ) -- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ์•ฝํ•™๋Œ€ํ•™ ์•ฝํ•™๊ณผ, 2021. 2. ํ™์„์ฐฝ.๊ณ ๋ฆฌํ˜• ํŽฉํƒ€์ด๋“œ๋Š” ์ผ๋ฐ˜์ ์œผ๋กœ ์„ ํ˜• ํŽฉํƒ€์ด๋“œ์— ๋น„ํ•ด ์ƒ์ฒด ๋‚ด์—์„œ ์•ˆ์ •ํ•˜๊ณ  ๊ตฌ์กฐ์˜ ์œ ๋™์„ฑ์„ ์ค„์ผ ์ˆ˜ ์žˆ๋Š” ์ด์ ์ด ์žˆ์–ด ์˜์•ฝํ•™์ ์œผ๋กœ ์œ ๋งํ•œ ์„ ๋„ ๋ฌผ์งˆ๋กœ ์•Œ๋ ค์ ธ ์žˆ๋‹ค. ์ด๋Ÿฌํ•œ ๊ณ ๋ฆฌํ˜• ํŽฉํƒ€์ด๋“œ ๋ฌผ์งˆ ์ค‘ ํ•˜๋‚˜์ธ Melicopteline์€ Melicope pteleifolia์˜ ๋‚˜๋ญ‡์žŽ์—์„œ ์ถ”์ถœ๋˜์—ˆ์œผ๋ฉฐ, Madin-Darby Canine Kidney Cell์—์„œ ์ธํ”Œ๋ฃจ์—”์ž A ๋ฐ”์ด๋Ÿฌ์Šค H1N1 ๋ฐ H9N2์— ๋Œ€ํ•œ ๊ฐ•ํ•œ ํ•ญ์ธํ”Œ๋ฃจ์—”์ž ํ™œ์„ฑ์„ ๋ณด์˜€๋‹ค. ๋ถ„๋ฆฌ๋œ Melicopteline ๊ตฐ ์ค‘์—์„œ๋„ hexahydropyrrolo[2,3-b]indole (HPI)์˜ ํŠน์ดํ•œ ํ—คํ…Œ๋กœ ์‚ฌ์ดํด ๊ตฌ์กฐ๋ฅผ ๊ฐ€์ง„ Melicopteline C, D, E๋Š” ๋” ๊ฐ•๋ ฅํ•œ ํ™œ์„ฑ์„ ๋‚˜ํƒ€๋‚ด์—ˆ๋‹ค. ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ์ด๋Ÿฌํ•œ HPI์˜ ๊ณจ๊ฒฉ์„ ๊ฐ€์ง„ Melicopteline์˜ ์ฒœ์—ฐ๋ฌผ ์ „ํ•ฉ์„ฑ์„ ์ง„ํ–‰ํ•˜์˜€์œผ๋ฉฐ, ์ด๋Š” ํ•ญ์ธํ”Œ๋ฃจ์—”์ž ์น˜๋ฃŒ์ œ๋ฅผ ์œ„ํ•œ ์˜์•ฝํ™”ํ•™์  ์—ฐ๊ตฌ์— ์ ์šฉํ•˜๊ณ ์ž ํ•œ๋‹ค. Melicopteline C์˜ ํ•ฉ์„ฑ์€ Tryptophan์ด ์‚ฐํ™”๋œ ๊ตฌ์กฐ์ธ 3a-hydroxy-HPI์™€ ์„ ํ˜• ํŽœํƒ€ํŽฉํƒ€์ด๋“œ ๋‘ ๋ถ€๋ถ„์œผ๋กœ ๋‚˜๋ˆ„์–ด ์ง„ํ–‰๋œ๋‹ค. L-tryptophan์˜ ์‚ฐํ™”์  ๊ณ ๋ฆฌํ™” ๋ฐ˜์‘์„ ํ†ตํ•ด ์ž…์ฒด ํŠน์ด์„ฑ์„ ์ง€๋‹Œ syn-cis์™€ anti-cis HPI, ๋‘ ๊ฐ€์ง€ ๋ถ€๋ถ„์ž…์ฒด์ด์„ฑ์งˆ์ฒด์˜ ๊ตฌ์กฐ๋ฅผ ๋™์‹œ์— ํ•ฉ์„ฑํ•˜์˜€๊ณ  ์ด์˜ ์ž…์ฒด ๊ตฌ์กฐ๋ฅผ ๊ทœ๋ช…ํ•˜๋Š” ๊ณผ์ •์ด ์ง„ํ–‰๋˜์—ˆ๋‹ค. ์ด๋ ‡๊ฒŒ ์–ป์–ด์ง„ 3a-hydroxy-HPI์™€ ์„ ํ˜• ํŽœํƒ€ํŽฉํƒ€์ด๋“œ์˜ ์•„๋งˆ์ด๋“œ ๊ฒฐํ•ฉ์„ ํ†ตํ•ด ๊ณ ๋ฆฌํ˜• ํŽฉํƒ€์ด๋“œ ํ™”ํ•ฉ๋ฌผ์„ ํ˜•์„ฑํ•˜์˜€๊ณ , ์ด๋Ÿฌํ•œ ํ•ฉ์„ฑ์ „๋žต์„ ํ†ตํ•ด 17๋‹จ๊ณ„์˜ ํ•ฉ์„ฑ ๊ณผ์ •๊ณผ Ltryptophan์„ ๊ธฐ์ค€์œผ๋กœ ์ „์ฒด ์ˆ˜์œจ 4.7%๋กœ Melicopteline C์˜ ํ•ฉ์„ฑ์„ ์™„๋ฃŒํ•˜์˜€๋‹ค. ์ถ”๊ฐ€์ ์œผ๋กœ, Melicopteline C์˜ ๋ถ€๋ถ„์ž…์ฒด์ด์„ฑ์งˆ์ฒด ๊ด€๊ณ„์ธ Melicopteline D์™€ ๋ณ€ํ˜•๋œ ํ•ฉ์„ฑ์ „๋žต์„ ํ†ตํ•ด ๋‹ค๋ฅธ ์•„๋ฏธ๋…ธ์‚ฐ ์‚ฌ์Šฌ์˜ ๊ตฌ์กฐ๋ฅผ ๊ฐ€์ง„ Melicopteline E์™€ ๋ถ€๋ถ„ ์ž…์ฒด ์ด์„ฑ์งˆ์ฒด๋ฅผ ํ•ฉ์„ฑํ•˜์˜€๋‹ค.Cyclic peptides are generally known as pharmaceutically promising candidates because they are more stable in vivo than linear peptides and can reduce structural fluidity. Melicopteline, one of such cyclic peptide substances, is extracted from leaves of Melicope ptelefolia and exhibits strong anti-influenza activity against influenza A viruses H1N1 and H9N2 in Madin-Darby Canine Kidney Cell. Among the separated Melicopteline groups, Melicopteline C, D, E, which has a unique heterocycle structure of Hexahydropyrrolo[2,3-b]indole (HPI), showed more robust activity. In this study, we have synthesized all of the natural products of Melicopteline with HPI skeletons and will apply them to the medicinal chemistry research for anti-influenza drugs. Melicopteline C is synthesized in two parts, 3a-hydroxy-HPI in which L-Tryptophan is oxidized and linear pentapeptide. An oxidative cyclization reaction of L-tryptophan simultaneously synthesized the structures of two diastereomers, syn-cis and anti-cis HPI, each having stereospecificity, to determine the stereospecific structure. A cyclic peptide compound is attempted by the amide formation between the obtained 3a-hydroxy-HPI and linear pentapeptide. The synthesis of Melicopteline C is completed with a total yield of 4.7% based on L-tryptophan. Additionally, we synthesized with Melicopterine D, a diasteromer of Melicopterine C, by using a similar synthesis strategy. Melicopterine E and diasteromer having other amino acids chain structure are also synthesized by the modified synthesis strategy.๊ตญ๋ฌธ์ดˆ๋ก.....................................................................................................i ๋ชฉ ์ฐจ.........................................................................................................iii Figure ๋ชฉ๋ก ..............................................................................................v Scheme ๋ชฉ๋ก ..........................................................................................vi Table ๋ชฉ๋ก..............................................................................................vii โ… . ์„œ ๋ก  .............................................................................................1 1. ์ž์—ฐ์— ์กด์žฌํ•˜๋Š” ๊ณ ๋ฆฌ ํ˜•ํƒœ ํŽฉํƒ€์ด๋“œ ์ฒœ์—ฐ๋ฌผ......................................1 2. Melicopteline์˜ ํ•ญ์ธํ”Œ๋ฃจ์—”์ž ํ™œ์„ฑ......................................................4 3. HPI ๊ณจ๊ฒฉ์„ ๊ฐ€์ง„ ์ฒœ์—ฐ๋ฌผ์˜ ์ „ํ•ฉ์„ฑ.........................................................6 โ…ก. ๋ณธ ๋ก ...................................................................................................10 1. ์—ญํ•ฉ์„ฑ ์ „๋žต.................................................................................. 10 2. ํ•ต์‹ฌ ์ค‘๊ฐ„์ฒด ํ•ฉ์„ฑ๊ณผ์ •................................................................. 12 2.1 ์„ ํƒ์ ์ธ HPI์˜ ํ•ฉ์„ฑ๊ณผ์ • .................................................... 12 2.2 HPI์˜ ์ž…์ฒด์„ ํƒ์„ฑ ์˜ˆ์ธก......................................................... 15 2.3 HPI์˜ ์ž…์ฒด ๊ตฌ์กฐ ๋ถ„์„........................................................... 18 2.4 ํ•ต์‹ฌ์ค‘๊ฐ„์ฒด HPI์˜ ๋งˆ๋ฌด๋ฆฌ ํ•ฉ์„ฑ๊ณผ์ •................................... 20 3. Melicopteline C, D์˜ ์ „ํ•ฉ์„ฑ..................................................... 23 3.1 ์„ ํ˜• ํŽœํƒ€ํŽฉํƒ€์ด๋“œ ํ™”ํ•ฉ๋ฌผ์˜ ํ•ฉ์„ฑ...................................... 23 3.2 Melicopteline C, D์˜ ์ „ํ•ฉ์„ฑ ์™„๋ฃŒ..................................... 26 4. Melicopteline E์˜ ์ „ํ•ฉ์„ฑ .................................................30 4.1 Melicopteline E์˜ ์„ ํ˜• ํŽœํƒ€ํŽฉํƒ€์ด๋“œ ํ™”ํ•ฉ๋ฌผ์˜ ํ•ฉ์„ฑ .... 30 4.2 Melicopteline E์™€ ๋ถ€๋ถ„ ์ž…์ฒด ์ด์„ฑ์งˆ์ฒด์˜ ์ „ํ•ฉ์„ฑ ์™„๋ฃŒ .. 32 5. ์ถ”์ถœ๋œ Melicopteline๊ณผ ํ•ฉ์„ฑ๋œ Melicopteline์˜ ๊ตฌ์กฐ๋น„๊ต 36 โ…ข. ๊ฒฐ ๋ก  .......................................................................................... 43 โ…ฃ. ์‹ค ํ—˜ .......................................................................................... 44 1. ํ•ต์‹ฌ์ค‘๊ฐ„์ฒด HPI์˜ ํ•ฉ์„ฑ.............................................................. 45 1.1 ์ž…์ฒด ์„ ํƒ์ ์ธ HPI์˜ ํ•ฉ์„ฑ๊ณผ์ •........................................... 45 1.2 3์ฐจ alcohol์˜ TBS protection ๋ฐ˜์‘ ์กฐ๊ฑด ........................ 50 1.3 Tosyl deprotection ๋ฐ˜์‘ ์กฐ๊ฑด ............................................ 53 1.4 3a-hydroxyl HPI์˜ ์ž…์ฒด๊ตฌ์กฐ ํ™•์ธ ๋ฐ˜์‘............................ 56 2. ํ•ต์‹ฌ์ค‘๊ฐ„์ฒด HPI์˜ ํ•ฉ์„ฑ.............................................................. 60 2.1 ์„ ํ˜• ํŽœํƒ€ํŽฉํƒ€์ด๋“œ์˜ ์•„๋งˆ์ด๋“œ ๊ฒฐํ•ฉ ๋ฐ˜์‘ ์กฐ๊ฑด .............. 62 2.2 ๊ฐ€์ˆ˜๋ถ„ํ•ด ๋ฐ˜์‘ ์กฐ๊ฑด............................................................... 68 3. ๋ฉœ๋ฆฌ์ฝฅํ…”๋ฆฐ์˜ ๋งˆ์ง€๋ง‰ ์ „ํ•ฉ์„ฑ ๊ณผ์ •............................................ 71 3.1 ์„ ํ˜• ํ—ฅ์‚ฌํŽฉํƒ€์ด๋“œ์˜ ์•„๋งˆ์ด๋“œ ๊ฒฐํ•ฉ ๋ฐ˜์‘ ์กฐ๊ฑด .............. 71 3.2 ๊ณ ๋ฆฌํ˜• ํ—ฅ์‚ฌํŽฉํƒ€์ด๋“œ์˜ ์•„๋งˆ์ด๋“œ ๊ฒฐํ•ฉ ๋ฐ˜์‘์กฐ๊ฑด............. 78 3.3 Bn deprotection ๋ฐ˜์‘ ์กฐ๊ฑด................................................. 85 3.4 TBS deprotection ๋ฐ˜์‘ ์กฐ๊ฑด............................................... 88 โ…ค. ์ฐธ๊ณ ๋ฌธํ—Œ................................................................................... 93 โ…ฅ. ๋ถ€ ๋ก .......................................................................................... 95 โ…ฆ. Abstract.................................................................................. 130Maste

    ์ ๋ถ„ํ˜• ์ดˆ์ŒํŒŒ ์œ ๋Ÿ‰๊ณ„๋ฅผ ์ด์šฉํ•œ MPI์—”์ง„์˜ ๋น„์ •์ƒ์ƒํƒœ ๊ณต์—ฐ๋น„ ์ œ์–ด

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :๊ธฐ๊ณ„๊ณตํ•™๊ณผ,1999.Maste

    ๊ฒ€์ง€๊ธฐ ์ž๋ฃŒ๋ฅผ ์ด์šฉํ•œ ์‹ ํ˜ธํ™”๋œ ๋„์‹œ๋ถ€๊ฐ€๋กœ์—์„œ์˜ ๋งํฌํ†ตํ–‰์‹œ๊ฐ„ ์ถ”์ •์— ๋Œ€ํ•œ ์—ฐ๊ตฌ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธๅคงๅญธๆ ก ๅคงๅญธ้™ข :ๅœŸๆœจๅทฅๅญธ็ง‘ ้ƒฝๅธ‚ๅทฅๅญธๅฐˆๆ”ป,1996.Maste
    corecore